The DOI matches its Crossref record; 73 of the 74 references it cites were found in a registry or an index.
The Science of Vascular Contributions to Cognitive Impairment and Dementia (VCID): A Framework for Advancing Research Priorities in the Cerebrovascular Biology of Cognitive Decline
Open accessAbstract
The World Health Organization reports that 47.5 million people are affected by dementia worldwide. With aging populations and 7.7 million new cases each year, the burden of illness due to dementia approaches crisis proportions. Despite significant advances in our understanding of the biology of Alzheimer's disease (AD), the leading dementia diagnosis, the actual causes of dementia in affected individuals are unknown except for rare fully penetrant genetic forms. Evidence from epidemiology and pathology studies indicates that damage to the vascular system is associated with an increased risk of many types of dementia. Both Alzheimer's pathology and cerebrovascular disease increase with age. How AD affects small blood vessel function and how vascular dysfunction contributes to the molecular pathology of Alzheimer's are areas of intense research. The science of vascular contributions to cognitive impairment and dementia (VCID) integrates diverse aspects of biology and incorporates the roles of multiple cell types that support the function of neural tissue. Because of the proven ability to prevent and treat cardiovascular disease and hypertension with population benefits for heart and stroke outcomes, it is proposed that understanding and targeting the biological mechanisms of VCID can have a similarly positive impact on public health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A framework for research priorities in the cerebrovascular biology of cognitive decline has been proposed 164 . The priorities include the development and validation of imaging and biospecimen‐based biomarkers, better experimental models, and increased understanding of the underlying molecular and physiological mechanisms – white matter disease, infarction, microhemorrhage, vascular autoregulation”
From Mental health care for older adults: recent advances and new directions in clinical practice and research (2022) · cites this paper as [164]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Self-citationDiagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)
American Psychiatric Association (2000) · doi:10.1176/appi.books.9780890423349 · Cited by 11,069
Diagnostic and Statistical Manual of Mental Disorders(DSM)
Leong, F. T. L. (2008) · Sage eBooks · doi:10.4135/9781412963978.n182 · Cited by 10,861
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Feigin, V. L., Forouzanfar, M. H., Krishnamurthi, R., Mensah, G. A., Connor, M., Bennett, D. A., Moran, A. E., Sacco, R. L., Anderson, L., Truelsen, T., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61953-4 · Cited by 3,899
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Hyman, B. T., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.10.007 · Cited by 3,092
A protein factor essential for microtubule assembly
Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., & Kirschner, M. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.5.1858 · Cited by 3,089
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Cited by
Sorted by citations
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
Iadecola, C. (2017) · Neuron · doi:10.1016/j.neuron.2017.07.030 · Cited by 2,480
Cerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways
Greenberg, S. M., Bacskai, B. J., Hernandez-Guillamon, M., Pruzin, J., Sperling, R., & van Veluw, S. J. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0281-2 · Cited by 947
Toth, P., Tarantini, S., Csiszar, A., & Ungvari, Z. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00581.2016 · Cited by 522
Reynolds, C. F., Jeste, D. V., Sachdev, P. S., & Blazer, D. G. (2022) · World Psychiatry · doi:10.1002/wps.20996 · Cited by 465
Tarantini, S., Tran, C. H. T., Gordon, G. R., Ungvari, Z., & Csiszar, A. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2016.11.004 · Cited by 411
Vascular Cognitive Impairment (VCI)
Rundek, T., Tolea, M. I., Ariko, T., Fagerli, E. A., & Camargo, C. J. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01170-y · Cited by 347
Zloković, B. V., Gottesman, R. F., Bernstein, K. E., Seshadri, S. S., McKee, A. C., Snyder, H. M., Greenberg, S. M., Yaffe, K. S., Schaffer, C. B., Yuan, C., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12157 · Cited by 252
Self-citationBesser, L. M., Kukull, W. A., Teylan, M. A., Bigio, E. H., Cairns, N. J., Kofler, J. K., Montine, T. J., Schneider, J. A., & Nelson, P. T. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly049 · Cited by 224
Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer’s Disease
Mullins, R. J., Diehl, T. C., Chia, C. W., & Kapogiannis, D. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00118 · Cited by 227
Cerebral small vessel disease genomics and its implications across the lifespan
Sargurupremraj, M., Suzuki, H., Jian, X., Sarnowski, C., Evans, T. E., Bis, J. C., Eiriksdottir, G., Sakaue, S., Terzikhan, N., Habes, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19111-2 · Cited by 220
Benefits of exercise training on cerebrovascular and cognitive function in ageing
Bliss, E., Wong, R. H. X., Howe, P. R. C., & Mills, D. E. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20957807 · Cited by 226
Extracellular matrix inflammation in vascular cognitive impairment and dementia
Rosenberg, G. A. (2017) · Clinical Science · doi:10.1042/cs20160604 · Cited by 214
Dementia in Africa: current evidence, knowledge gaps, and future directions
Akinyemi, R. O., Yaria, J., Ojagbemi, A., Guerchet, M., Okubadejo, N., Njamnshi, A. K., Sarfo, F. S., Akpalu, A., Ogbole, G., Ayantayo, T., et al. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12432 · Cited by 184
Reactive astrocytes: The nexus of pathological and clinical hallmarks of Alzheimer’s disease
Price, B. R., Johnson, L. A., & Norris, C. M. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101335 · Cited by 184
Vascular contributions to Alzheimer's disease
Eisenmenger, L. B., Peret, A., Famakin, B. M., Spahic, A., Roberts, G. S., Bockholt, J. H., Johnson, K. M., & Paulsen, J. S. (2022) · Translational research · doi:10.1016/j.trsl.2022.12.003 · Cited by 183
Andjelkovic, A. V., Situ, M., Citalán‐Madrid, A. F., Stamatovic, S. M., Xiang, J., & Keep, R. F. (2023) · Stroke · doi:10.1161/strokeaha.122.040578 · Cited by 190
Pang, B., Dong, G., Pang, T., Sun, X., Liu, X., Nie, Y., & Chang, X. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1422686 · Cited by 175
Fu, Z., Caprihan, A., Chen, J., Du, Y., Adair, J. C., Jing Sui (Beijing Normal University), my correct affiliation is beijing normal university, N. Q. U. O. S. A. T., Rosenberg, G. A., & Calhoun, V. D. (2019) · Human Brain Mapping · doi:10.1002/hbm.24591 · Cited by 172
Cogswell, P. M., Barakos, J. A., Barkhof, F., Benzinger, T. L. S., Jack, C. R., Poussaint, T. Y., Raji, C. A., Ramanan, V. K., & Whitlow, C. T. (2022) · American Journal of Neuroradiology · doi:10.3174/ajnr.a7586 · Cited by 150
Obesity-related cognitive impairment: The role of endothelial dysfunction
Buie, J. N. J., Watson, L. S., Smith, C. J., & Sims‐Robinson, C. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104580 · Cited by 138
Causes and consequences of baseline cerebral blood flow reductions in Alzheimer’s disease
Bracko, O., Hernández, J. C. C., Park, L., Nishimura, N., & Schaffer, C. B. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20982383 · Cited by 127
The pathogenesis of cerebral small vessel disease and vascular cognitive impairment
Markus, H. S., & Joutel, A. (2025) · Physiological Reviews · doi:10.1152/physrev.00028.2024 · Cited by 140
Cerebral Microvascular Accumulation of Tau Oligomers in Alzheimer’s Disease and Related Tauopathies
Castillo-Carranza, D. L., Nilson, A. N., Van Skike, C. E., Jahrling, J. B., Patel, K., Garach, P., Gerson, J. E., Sengupta, U., Abisambra, J., Nelson, P., et al. (2017) · Aging and disease · doi:10.14336/ad.2017.0112 · Cited by 118
Pericyte Structural Remodeling in Cerebrovascular Health and Homeostasis
Berthiaume, A., Hartmann, D. A., Majesky, M. W., Bhat, N. R., & Shih, A. Y. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00210 · Cited by 117
Rodent Models of Vascular Cognitive Impairment
Yang, Y. R., Kimura‐Ohba, S., Thompson, J., & Rosenberg, G. A. (2016) · Translational Stroke Research · doi:10.1007/s12975-016-0486-2 · Cited by 109
Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer’s Disease
Parodi‐Rullán, R. M., Sone, J. Y., & Fossati, S. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190357 · Cited by 110
Amyloid-Related Imaging Abnormalities: An Update
Roytman, M., Mashriqi, F., Al-Tawil, K., Schulz, P. E., Zaharchuk, G., Benzinger, T. L. S., & Franceschi, A. M. (2023) · American Journal of Roentgenology · doi:10.2214/ajr.22.28461 · Cited by 99
MR/PET Imaging of the Cardiovascular System
Robson, P. M., Dey, D., Newby, D. E., Berman, D. S., Li, D., Fayad, Z. A., & Dweck, M. R. (2017) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2017.07.008 · Cited by 96
Mao, L., Yang, T., Li, X., Xia, L., Sun, Y., Zhao, Y., Zhang, W., Gao, Y., Sun, B., & Zhang, F. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18764083 · Cited by 94
Hayden, M. R. (2019) · Brain Sciences · doi:10.3390/brainsci9100262 · Cited by 95
Potential Therapeutics for Vascular Cognitive Impairment and Dementia
Sun, M. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666171016164734 · Cited by 87
Bosetti, F., Galis, Z. S., Bynoe, M. S., Charette, M., Cipolla, M. J., del Zoppo, G. J., Gould, D. B., Hatsukami, T. S., Jones, T. L. Z., Koenig, J. I., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.004389 · Cited by 86
Self-citationKhan, M. B., Hafez, S. S., Hoda, M. N., Baban, B., Wagner, J. D., Awad, M. E., Sangabathula, H., Haigh, S. B., Elsalanty, M. E., Waller, J. L., et al. (2017) · Translational Stroke Research · doi:10.1007/s12975-017-0555-1 · Cited by 85
Tuttolomondo, A., Petta, S., Casuccio, A., Maida, C. D., Corte, V. D., Daidone, M., Raimondo, D. D., Pecoraro, R., Fonte, R., Cirrincione, A., et al. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0670-7 · Cited by 80
McConnell, H., Li, Z., Woltjer, R. L., & Mishra, A. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.04.005 · Cited by 74
Hay, M., Polt, R. L., Heien, M. L., Vanderah, T. W., Largent‐Milnes, T. M., Rodgers, K. E., Falk, T., Bartlett, M. J., Doyle, K. P., & Konhilas, J. P. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.254854 · Cited by 71
Maurice, T. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1838483 · Cited by 71
Dynamics of middle cerebral artery blood flow velocity during moderate-intensity exercise
Billinger, S. A., Craig, J. C., Kwapiszeski, S. J., Sisante, J.-F. V., Vidoni, E. D., Maletsky, R., & Poole, D. C. (2017) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00995.2016 · Cited by 66
Effects of sulforaphane in the central nervous system
Huang, C., Wu, J., Chen, D., Jin, J., Wu, Y. H., & Chen, Z. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.03.010 · Cited by 71
Statin use and dementia risk: A systematic review and updated meta‐analysis
Filho, F. L. W., Lopes, P. R. M., de Almeida, A. M., Sano, V. K. T., Tamashiro, F. M., Gonçalves, O. R., de Moraes, F. C. A., Kreuz, M., Kelly, F. A., & Feitoza, P. V. S. (2025) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.70039 · Cited by 68
Placental growth factor as a sensitive biomarker for vascular cognitive impairment
Hinman, J. D., Elahi, F. M., Chong, D. S., Radabaugh, H. L., Ferguson, A. R., Maillard, P., Thompson, J. F., Rosenberg, G. A., Sagare, A. P., Moghekar, A., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12974 · Cited by 63
Ferroptosis of Microglia in Aging Human White Matter Injury
Adeniyi, P. A., Gong, X., MacGregor, E., Degener-O’Brien, K., McClendon, E., Garcia, M., Romero, O., Russell, J., Srivastava, T., Miller, J. A., et al. (2023) · Annals of Neurology · doi:10.1002/ana.26770 · Cited by 62
Carey, A. M., & Fossati, S. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12871 · Cited by 62
Alkhalifa, A. E., Mokhlf, A. A., Ali, H., Al-Ghraiybah, N. F., & Syropoulou, V. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15090437 · Cited by 68
Blood Pressure and Vascular Cognitive Impairment
Levine, D. A., Springer, M. V., & Brodtmann, A. G. (2022) · Stroke · doi:10.1161/strokeaha.121.036140 · Cited by 63
Tarantini, S., Yabluchanksiy, A., Fülöp, G. Á., Hertelendy, P., Valcarcel‐Ares, M. N., Kiss, T., Bagwell, J. M., O’Connor, D., Farkas, E., Sorond, F. A., et al. (2017) · GeroScience · doi:10.1007/s11357-017-0003-x · Cited by 55
Smith, E. E., Aparicio, H. J., Gottesman, R. F., Goyal, M. S., Greenberg, S. M., Schneider, J. A., Sorond, F. A., & Wright, C. B. (2025) · Stroke · doi:10.1161/str.0000000000000494 · Cited by 64
Mukli, P., Pinto, C. B., Owens, C. D., Csípő, T., Lipécz, Á., Szarvas, Z., Péterfi, A., Pinaffi‐Langley, A. C. D. C., Hoffmeister, J. R., Rácz, F. S., et al. (2023) · Advanced Science · doi:10.1002/advs.202303516 · Cited by 53
Precision Aging: Applying Precision Medicine to the Field of Cognitive Aging
Ryan, L., Hay, M., Huentelman, M. J., Duarte, A., Rundek, T., Levin, B. E., Soldan, A., Pettigrew, C. A., Mehl, M. R., & Barnes, C. A. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00128 · Cited by 55
Brain Vasculature and Cognition
Fouda, A. Y., Fagan, S. C., & Ergul, A. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311906 · Cited by 53
Canepa, E., Parodi‐Rullán, R. M., Vázquez‐Torres, R., Gamallo‐Lana, B., Guzman‐Hernandez, R. A., Lemon, N. L., Angiulli, F., Debure, L., Ilies, M. A., Østergaard, L., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13063 · Cited by 54
White matter abnormalities are key components of cerebrovascular disease impacting cognitive decline
Vemuri, P., Graff‐Radford, J., Lesnick, T. G., Przybelski, S. A., Reid, R. I., Reddy, A. L., Lowe, V. J., Mielke, M. M., Machulda, M. M., Petersen, R. C., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab076 · Cited by 49
van Veluw, S. J., Benveniste, H., Bakker, E. N. T. P., Carare, R. O., Greenberg, S. M., Iliff, J. J., Lorthois, S., Nostrand, W. E. V., Petzold, G. C., Shih, A. Y., et al. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05277-1 · Cited by 50
Constans, A., Pin-Barre, C., Temprado, J.-J., Decherchi, P., & Laurin, J. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00164 · Cited by 52
Ajoolabady, A., Aslkhodapasandhokmabad, H., Henninger, N., Demillard, L. J., Nikanfar, M., Nourazarian, A., & Ren, J. T. (2021) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13500 · Cited by 48
Rosenberg, G. A. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14218 · Cited by 45
Gladman, J. T., Corriveau, R. A., Debette, S., Dichgans, M., Greenberg, S. M., Sachdev, P. S., Wardlaw, J. M., & Biessels, G. J. (2019) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.09.017 · Cited by 42
Self-citationCalcineurin proteolysis in astrocytes: Implications for impaired synaptic function
Pleiss, M. M., Sompol, P. M., Kraner, S. D., Abdul, H. M., Furman, J. L., Guttmann, R. P., Wilcock, D. M., Nelson, P. T., & Norris, C. M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.05.007 · Cited by 43
Al‐Khazraji, B. K., Appleton, C. T., Beier, F., Birmingham, T. B., & Shoemaker, J. K. (2018) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2018.01.011 · Cited by 42
Vasodilator dysfunction and oligodendrocyte dysmaturation in aging white matter
Bagi, Z. A., Brandner, D. D., Le, P., McNeal, D. W., Gong, X., Dou, H., Fulton, D. J., Beller, A., Ngyuen, T. D., Larson, E. B., et al. (2017) · Annals of Neurology · doi:10.1002/ana.25129 · Cited by 41
Owens, C. D., Mukli, P., Csípő, T., Lipécz, Á., Silva-Palacios, F., Dasari, T. W., Tarantini, S., Gardner, A. W., Montgomery, P. S., Waldstein, S. R., et al. (2022) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00616.2021 · Cited by 40
Iron-responsive-like elements and neurodegenerative ferroptosisPreprint
Rogers, J. T., & Cahill, C. M. (2020) · Learning & Memory · doi:10.1101/lm.052282.120 · Cited by 41
de Montgolfier, O., Thorin‐Trescases, N., & Thorin, É. (2020) · American Journal of Hypertension · doi:10.1093/ajh/hpaa001 · Cited by 45
More than just risk for Alzheimer’s disease: APOE ε4's impact on the aging brain
Palmer, J. M., Huentelman, M. J., & Ryan, L. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.06.003 · Cited by 39
Diabetic Retinopathy and Dementia in Type 1 Diabetes
Rodill, L. G., Exalto, L. G., Gilsanz, P., Biessels, G. J., Quesenberry, C. P., & Whitmer, R. A. (2017) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000230 · Cited by 36
Effects of Plasma Lipids and Statins on Cognitive Function
Li, R., Wang, T., Lyu, P., Liu, Y., Chen, W., Fan, M., & Xu, J. (2018) · Chinese Medical Journal · doi:10.4103/0366-6999.225062 · Cited by 40
Smoking is associated with impaired verbal learning and memory performance in women more than men
Lewis, C. R., Talboom, J. S., Both, M. D. D., Schmidt, A. M., Naymik, M., Haberg, A. K., Rundek, T., Levin, B. E., Hoscheidt, S. M., Bolla, Y., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-88923-z · Cited by 38
AT1 Receptors: Their Actions from Hypertension to Cognitive Impairment
Wu, H., Sun, Q., Yuan, S., Wang, J., Li, F., Gao, H., Chen, X., Yang, R., & Xu, J. (2022) · Cardiovascular Toxicology · doi:10.1007/s12012-022-09730-0 · Cited by 37
Hoyer-Kimura, C. H., Konhilas, J. P., Mansour, H. M., Polt, R. L., Doyle, K. P., Billheimer, D. D., & Hay, M. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02281-1 · Cited by 36
Mukli, P., Detwiler, S., Owens, C. D., Csípő, T., Lipécz, Á., Pinto, C. B., Tarantini, S., Nyúl‐Tóth, Á., Balasubramanian, P., Hoffmeister, J. R., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1052451 · Cited by 34
Thakore, P., Yamasaki, E., Ali, S., Solano, A. S., Labelle‐Dumais, C., Gao, X. P., Chaumeil, M. M., Gould, D. B., & Earley, S. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2306479120 · Cited by 33
Hayden, M. R., & Tyagi, S. (2021) · Medicina · doi:10.3390/medicina58010016 · Cited by 35
Cerebral Superficial Siderosis
Weidauer, S., Neuhaus, E., & Hattingen, E. (2022) · Clinical Neuroradiology · doi:10.1007/s00062-022-01231-5 · Cited by 34
Merlini, M., Shi, Y., Keller, S., Savarese, G., Akhmedov, A., Derungs, R., Spescha, R. D., Kulic, L., Nitsch, R. M., Lüscher, T. F., et al. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00607.2016 · Cited by 29
Regulatory microRNAs and vascular cognitive impairment and dementia
Zhang, J., Sun, P., Zhou, C., Zhang, X., Ma, F., Xu, Y., Hamblin, M. H., & Yin, K. (2020) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13472 · Cited by 28
Retinal tissue hypoperfusion in patients with clinical Alzheimer’s disease
Gameiro, G. R., Jiang, H., Liu, Y., Deng, Y., Sun, X., Nascentes, B., Baumel, B. S., Rundek, T., & Wang, J. (2018) · Eye and Vision · doi:10.1186/s40662-018-0115-0 · Cited by 29
Vascular cognitive impairment and dementia: An early career researcher perspective
Silva, N. C. B. S., Bracko, O., Nelson, A. R., de Oliveira, F. F., Robison, L. S., Shaaban, C. E., Hainsworth, A. H., & Price, B. R. (2022) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12310 · Cited by 34
Association of cerebral microvascular dysfunction and white matter injury in Alzheimer’s disease
Bagi, Z. A., Kroenke, C. D., Fopiano, K. A., Tian, Y., Filosa, J. A., Sherman, L. S., Larson, E. B., Keene, C. D., Degener-O’Brien, K., Adeniyi, P. A., et al. (2022) · GeroScience · doi:10.1007/s11357-022-00585-5 · Cited by 27
Myasoedova, E., Sattui, S. E., Lee, J., O'Brien, J. T., & Makris, U. E. (2024) · The Lancet Rheumatology · doi:10.1016/s2665-9913(24)00190-5 · Cited by 29
In search of multimodal brain alterations in Alzheimer's and Binswanger's disease
Fu, Z., Iraji, A., Caprihan, A., Adair, J. C., Jing Sui (Beijing Normal University), my correct affiliation is beijing normal university, N. Q. U. O. S. A. T., Rosenberg, G. A., & Calhoun, V. D. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101937 · Cited by 25
Vascular Contributions to Cognitive Impairment and Treatments with Traditional Chinese Medicine
Zhou, X., Cui, G., Tseng, H. H. L., Lee, S. M., Leung, G., Chan, S., Kwan, Y. W., & Hoi, M. P. M. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/9627258 · Cited by 26
Cerebrovascular Blood Flow Design and Regulation; Vulnerability in Aging Brain
Wilson, D. F., & Matschinsky, F. M. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.584891 · Cited by 24
Neuropharmacology of synaptic plasticity: pathways to cognitive resilience in healthy aging
Goel, F., Singh, P., Nand, S., & Yadav, D. K. (2026) · 3 Biotech · doi:10.1007/s13205-025-04673-z · Cited by 24
Hayden, M. R., Grant, D. G., Aroor, A. R., & DeMarco, V. G. (2018) · Neuroglia · doi:10.3390/neuroglia1020021 · Cited by 23
PDE5 inhibitor drugs for use in dementia
Hainsworth, A. H., Arancio, O., Elahi, F. M., Isaacs, J. D., & Cheng, F. (2023) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12412 · Cited by 22
He, Y., He, T., Li, H., Chen, W., Zhong, B., Wu, Y., Chen, R., Hu, Y., Ma, H., Wu, B., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116428 · Cited by 22
Cognitive Impairment after Lacunar Stroke and the Risk of Recurrent Stroke and Death
Kwan, A., Wei, J., Dowling, N. M., Power, M. C., Nadareishvili, Z., & SPS3 Study Group (2021) · Cerebrovascular Diseases · doi:10.1159/000514261 · Cited by 21
WMH Contributions to Cognitive Impairment: Rationale and Design of the Diverse VCID Study
DeCarli, C. S., Rajan, K. B., Jin, L., Hinman, J. D., Johnson, D. K., Harvey, D. J., Fornage, M., Beiser, A., Gonzalez, H., Kukull, W. A., et al. (2024) · Stroke · doi:10.1161/strokeaha.124.045903 · Cited by 20
An introduction to therapeutic approaches to vascular cognitive impairment
Hainsworth, A. H., Elahi, F. M., & Corriveau, R. A. (2021) · Cerebral Circulation - Cognition and Behavior · doi:10.1016/j.cccb.2021.100033 · Cited by 19
Self-citationBranyan, K., Labelle‐Dumais, C., Wang, X., Hayashi, G., Lee, B., Peltz, Z., Gorman, S., Li, B. Q., Mao, M., & Gould, D. B. (2022) · Matrix Biology · doi:10.1016/j.matbio.2022.11.007 · Cited by 18
Luehrs, R. E., Moreau, K. L., Pierce, G. L., Wamboldt, F. S., Aloia, M. S., Weinberger, H. D., Make, B. J., Bowler, R. P., Crapo, J. D., Meschede, K., et al. (2021) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00477.2020 · Cited by 19
Multiple Faces of Cerebral Small Vessel Diseases
Gurol, M. E., Sacco, R. L., & McCullough, L. D. (2019) · Stroke · doi:10.1161/strokeaha.119.027969 · Cited by 17
Tarafdar, A., Wolska, N., Krisp, C., Schlüter, H., & Pula, G. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102287 · Cited by 18
Vascular Effects on Cerebrovascular Permeability and Neurodegeneration
Sulimai, N., Brown, J. D., & Lominadze, D. G. (2023) · Biomolecules · doi:10.3390/biom13040648 · Cited by 17
Hyperfibrinogenemia-mediated astrocyte activation
Clark, V. D., Layson, A., Charkviani, M., Muradashvili, N., & Lominadze, D. G. (2018) · Brain Research · doi:10.1016/j.brainres.2018.08.023 · Cited by 17
Kirkpatrick, A. C., Stoner, J. A., Dale, G. L., Rabadi, M. H., & Prodan, C. I. (2019) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2019.06.033 · Cited by 17
Arterial Changes Connecting Hypertension to Alzheimer’s Disease and Related Dementias
Burke, G. L., & Hughes, T. M. (2021) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.10.018 · Cited by 17
Microvascular burden and long-term risk of stroke and dementia in type 2 diabetes mellitus
Liu, Y., Zhao, J., Han, W.-W., Yang, H., Wu, X.-B., Xie, F., Wang, H., Wang, J., Zhao, X., Wan, Z., et al. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.03.053 · Cited by 17
Vascular risk, gait, behavioral, and plasma indicators of VCID
Raghavan, S., Przybelski, S. A., Lesnick, T. G., Fought, A. J., Reid, R. I., Gebre, R. K., Windham, B. G., Algeciras‐Schimnich, A., Machulda, M. M., Vassilaki, M. E., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13540 · Cited by 16
Muradashvili, N., Charkviani, M., Sulimai, N., Tyagi, N., Crosby, J. R., & Lominadze, D. G. (2020) · Brain Research · doi:10.1016/j.brainres.2020.147208 · Cited by 16
Metadata
- Authors
- Corriveau, R. A., Bosetti, F., Emr, M., Gladman, J. T., Koenig, J. I., Moy, C. S., Pahigiannis, K., Waddy, S. P., & Koroshetz, W.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Corriveau, Roderick A.
- ORCID
- Venue
- Cellular and Molecular Neurobiology
- Published
- 2016-03
- Volume
- 36
- Issue
- 2
- Pages
- 281-288
- ISSN
- 0272-4340 (ISSN-L)
- 1573-6830
- PMC
- PMC4859348
- OpenAlex
- W2340837185
- Cited by
- 240
- References
- 74
- Citations by year
- 2026: 22 · 2025: 32 · 2024: 29 · 2023: 22 · 2022: 30 · 2021: 20 · 2020: 22 · 2019: 21 · 2018: 14 · 2017: 16 · 2016: 12
- FWCI
- 1.83
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cellular and Molecular Neurobiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (Z99 NS999999)
- Topics
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- cerebrovascular disease, Alzheimer's disease, cognitive decline, vascular dysfunction, dementia risk factors, research priorities, vascular biology, dementia prevention
- MeSH terms
- Animals, Humans, Models, Biological, Research, Dementia, Vascular, Cost of Illness, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review